Bibliography
- NORMAN P: PDE4 inhibitors 2001 patent and literature activity 2000 — September 2001. Expert Opin. Ther. Patents(2002) 12:93–112.
- •Recent review of the field from the patent perspective.
- MONTANA JG, DYKE HJ: Update onthe therapeutic potential of PDE4 inhibi-tors. Expert Opin. Investig. Drugs (2002) 11:1–13.
- •Updated review of recent clinical developments.
- HUANG Z, DUCHARME Y, MACDO ALD D, ROBICHAUD A: The next generation of PDE4 inhibitors. Carr. Opin. Chem. Biol. (2001) 5(4):432–438.
- •Review from an alternative perspective.
- STURTON RG, BUTT NM, PALFAI SPet al.: Molecular and cellular profile of the structurally novel phosphodiesterase (PDE)-4 inhibitor, BAY 19–8004. Am. J. Respir. Grit. Care Med. (2000) 161:A200.
Website
- •The in vitro profile of lirirnilast.
- http://www.gsk.com/financial/ product_pipeline.htm
- http://www.altana.com/root/ index.php?langen&page_id261